NASDAQ : CGEN
Compugen Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 1.98 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 187.55M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Compugen Ltd. (CGEN) reported revenue of 74.00M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 74.00M | 72.76M | 27.86M | 33.46M | 7.50M | 6.00M |
| Cost of Revenue | 9.70M | 9.25M | 7.93M | 2.00M | 975.00K | 680.00K |
| Gross Profit | 64.30M | 63.51M | 19.93M | 31.45M | 6.53M | 5.32M |
| Selling, General & Admin | 9.41M | 9.43M | 10.02M | 9.97M | 11.25M | 11.70M |
| Research & Development | 24.59M | 22.76M | 24.81M | 34.47M | 30.65M | 28.69M |
| Operating Expenses | 34.00M | 32.19M | 34.83M | 44.45M | 41.90M | 40.39M |
| Operating Income | 30.30M | 31.33M | -14.89M | -12.99M | -35.37M | -35.07M |
| Interest & Investment Income | 4.37M | 3.90M | 3.49M | 2.96M | 1.44M | 894.00K |
| Currency Exchange Gain (Loss) | 259.00K | -310.00K | -20.00K | 5.00K | 340.00K | -1.00K |
| Other Non Operating Income (Expenses) | -28.00K | -28.00K | -34.00K | -31.00K | -27.00K | -25.00K |
| EBT Excluding Unusual Items | 34.90M | 34.89M | -11.46M | -10.06M | -33.62M | -34.21M |
| Gain (Loss) on Sale of Investments | 341.00K | 503.00K | 1.75M | 281.00K | ||
| Gain (Loss) on Sale of Assets | 1.00K | 1.00K | -7.00K | -12.00K | 3.00K | |
| Pretax Income | 35.24M | 35.40M | -9.71M | -9.78M | -33.64M | -34.20M |
| Income Tax Expense | 52.00K | 54.00K | 4.52M | 8.97M | 58.00K | |
| Net Income | 35.19M | 35.34M | -14.23M | -18.75M | -33.69M | -34.20M |
| Net Income to Common | 35.19M | 35.34M | -14.23M | -18.75M | -33.69M | -34.20M |
| Shares Outstanding (Basic) | 94.27M | 93.43M | 89.53M | 87.63M | 86.56M | 84.20M |
| Shares Outstanding (Diluted) | 94.66M | 93.82M | 89.53M | 87.63M | 86.56M | 84.20M |
| EPS (Basic) | 0.37 | 0.38 | -0.16 | -0.21 | -0.39 | -0.41 |
| EPS (Diluted) | 0.37 | 0.38 | -0.16 | -0.21 | -0.39 | -0.41 |
| Free Cash Flow | 28.14M | 31.33M | 49.49M | -36.06M | -34.59M | -22.98M |
| Free Cash Flow Per Share | 0.30 | 0.33 | 0.55 | -0.41 | -0.40 | -0.27 |
| Gross Margin | 86.89% | 87.29% | 71.54% | 94.01% | 87.00% | 88.67% |
| Operating Margin | 40.94% | 43.05% | -53.44% | -38.83% | -471.65% | -584.57% |
| Profit Margin | 47.55% | 48.57% | -51.07% | -56.05% | -449.25% | -570.05% |
| Free Cash Flow Margin | 38.02% | 43.05% | 177.60% | -107.77% | -461.20% | -383.05% |
| EBITDA | 30.68M | 31.80M | -14.40M | -12.52M | -34.89M | -34.61M |
| EBITDA Margin | 41.45% | 43.70% | -51.70% | -37.41% | ||
| D&A For EBITDA | 380.00K | 475.00K | 486.00K | 476.00K | 482.00K | 461.00K |
| EBIT | 30.30M | 31.33M | -14.89M | -12.99M | -35.37M | -35.07M |
| EBIT Margin | 40.94% | 43.05% | -53.44% | -38.83% | ||
| Effective Tax Rate | 0.15% | 0.15% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.28M | 90.60M | 18.23M | 13.89M | 11.06M | 7.80M |
| Short-Term Investments | 115.02M | 55.04M | 85.03M | 36.80M | 72.29M | 109.25M |
| Cash & Short-Term Investments | 125.30M | 145.64M | 103.25M | 50.69M | 83.35M | 117.05M |
| Accounts Receivable | 680.00K | 61.00M | ||||
| Other Receivables | 3.43M | 150.00K | 127.00K | 92.00K | 85.00K | 57.00K |
| Receivables | 4.11M | 150.00K | 127.00K | 61.09M | 85.00K | 57.00K |
| Prepaid Expenses | 2.23M | 2.62M | 2.44M | 2.33M | 5.40M | |
| Restricted Cash | 365.00K | 362.00K | 713.00K | |||
| Total Current Assets | 129.41M | 148.02M | 106.00M | 114.58M | 86.12M | 123.22M |
| Property, Plant & Equipment | 3.11M | 3.20M | 3.69M | 2.54M | 3.36M | 3.90M |
| Other Long-Term Assets | 5.84M | 5.35M | 5.30M | 4.21M | 4.69M | 5.04M |
| Total Assets | 138.37M | 156.57M | 115.00M | 121.33M | 94.18M | 132.16M |
| Accounts Payable | 2.15M | 2.35M | 1.84M | 3.50M | 1.77M | 4.62M |
| Accrued Expenses | 8.40M | 8.73M | 8.24M | 10.98M | 9.21M | 8.08M |
| Current Portion of Leases | 623.00K | 521.00K | 448.00K | 632.00K | 613.00K | 768.00K |
| Current Unearned Revenue | 11.46M | 10.97M | 9.63M | 11.15M | ||
| Other Current Liabilities | 325.00K | 3.63M | ||||
| Total Current Liabilities | 22.63M | 22.57M | 20.16M | 26.27M | 11.92M | 17.10M |
| Long-Term Leases | 2.40M | 2.44M | 2.46M | 719.00K | 1.31M | 1.98M |
| Long-Term Unearned Revenue | 20.36M | 24.94M | 34.05M | 25.39M | ||
| Pension & Post-Retirement Benefits | 4.24M | 3.89M | 3.41M | 3.40M | 3.27M | 3.68M |
| Other Long-Term Liabilities | 2.71M | |||||
| Total Liabilities | 49.63M | 53.84M | 60.08M | 55.77M | 16.50M | 25.47M |
| Common Stock | 262.00K | 262.00K | 248.00K | 247.00K | 240.00K | 239.00K |
| Additional Paid-In Capital | 556.59M | 555.88M | 543.41M | 539.84M | 533.21M | 528.53M |
| Retained Earnings | -468.09M | -453.42M | -488.76M | -474.53M | -455.77M | -422.08M |
| Comprehensive Income & Other | -31.00K | 8.00K | 11.00K | 2.00K | ||
| Shareholders' Equity | 88.73M | 102.73M | 54.91M | 65.56M | 77.68M | 106.69M |
| Total Liabilities & Equity | 138.37M | 156.57M | 115.00M | 121.33M | 94.18M | 132.16M |
| Total Debt | 3.02M | 2.96M | 2.91M | 1.35M | 1.93M | 2.75M |
| Net Cash (Debt) | 122.28M | 142.68M | 100.34M | 49.33M | 81.42M | 114.30M |
| Net Cash Per Share | 1.29 | 1.52 | 1.12 | 0.56 | 0.94 | 1.36 |
| Filing Date Shares Outstanding | 94.72M | 94.55M | 93.51M | 89.53M | 86.62M | 86.46M |
| Total Common Shares Outstanding | 94.72M | 94.55M | 89.54M | 89.24M | 86.62M | 86.43M |
| Working Capital | 106.78M | 125.45M | 85.84M | 88.31M | 74.21M | 106.13M |
| Book Value Per Share | 0.94 | 1.09 | 0.61 | 0.73 | 0.90 | 1.23 |
| Tangible Book Value | 88.73M | 102.73M | 54.91M | 65.56M | 77.68M | 106.69M |
| Tangible Book Value Per Share | 0.94 | 1.09 | 0.61 | 0.73 | 0.90 | 1.23 |
| Machinery | 4.58M | 4.29M | 4.26M | 5.45M | 5.18M | |
| Leasehold Improvements | 2.32M | 2.31M | 2.31M | 2.31M | 2.32M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 35.19M | 35.34M | -14.23M | -18.75M | -33.69M | -34.20M |
| Depreciation & Amortization | 380.00K | 475.00K | 486.00K | 476.00K | 482.00K | 461.00K |
| Loss (Gain) From Sale of Assets | -3.00K | -1.00K | 7.00K | 12.00K | -3.00K | |
| Loss (Gain) From Sale of Investments | -302.00K | -485.00K | -1.57M | -280.00K | ||
| Stock-Based Compensation | 1.46M | 1.88M | 3.02M | 3.55M | 4.33M | 4.28M |
| Other Operating Activities | -900.00K | -231.00K | -149.00K | -179.00K | 312.00K | -42.00K |
| Change in Accounts Receivable | -680.00K | 61.00M | -61.00M | 2.00M | ||
| Change in Accounts Payable | 248.00K | 517.00K | -1.67M | 1.73M | -1.60M | 3.37M |
| Change in Unearned Revenue | -8.32M | -7.76M | 7.14M | 36.54M | ||
| Change in Other Net Operating Assets | 1.17M | 1.90M | -4.42M | 2.02M | -3.95M | 1.45M |
| Operating Cash Flow | 28.25M | 31.63M | 49.60M | -35.89M | -34.11M | -22.69M |
| Capital Expenditures | -116.00K | -306.00K | -118.00K | -172.00K | -477.00K | -292.00K |
| Sale of Property, Plant & Equipment | 4.00K | 1.00K | 1.00K | 2.00K | 3.00K | |
| Investment in Securities | -26.89M | 30.30M | -46.13M | 35.68M | 37.55M | 6.91M |
| Other Investing Activities | -10.00K | |||||
| Investing Cash Flow | -27.00M | 30.00M | -46.25M | 35.51M | 37.06M | 6.62M |
| Issuance of Common Stock | 1.85M | 10.61M | 554.00K | 3.08M | 353.00K | 16.84M |
| Repurchase of Common Stock | -4.00K | -4.00K | ||||
| Financing Cash Flow | 1.85M | 10.60M | 554.00K | 3.08M | 353.00K | 16.84M |
| Foreign Exchange Rate Adjustments | 718.00K | 135.00K | 68.00K | 129.00K | -393.00K | -59.00K |
| Net Cash Flow | 3.81M | 72.37M | 3.97M | 2.83M | 2.91M | 704.00K |
| Free Cash Flow | 28.14M | 31.33M | 49.49M | -36.06M | -34.59M | -22.98M |
| Free Cash Flow Margin | 38.02% | 43.05% | 177.60% | -107.77% | -461.20% | -383.05% |
| Free Cash Flow Per Share | 0.30 | 0.33 | 0.55 | -0.41 | -0.40 | -0.27 |
| Levered Free Cash Flow | 22.22M | 24.33M | 49.31M | -51.05M | -19.40M | -11.88M |
| Unlevered Free Cash Flow | 22.22M | 24.33M | 49.31M | -51.05M | -19.40M | -11.88M |
| Change in Working Capital | -7.58M | -5.35M | 62.05M | -20.71M | -5.55M | 6.82M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 187.55M | 143.11M | 136.99M | 174.89M | 62.00M | 370.72M |
| Enterprise Value | 65.28M | 59.97M | 27.23M | 118.79M | -24.24M | 271.27M |
| Last Close Price | 1.98 | 1.53 | 1.53 | 1.98 | 0.72 | 4.30 |
| PE Ratio | 5.30 | 4.05 | ||||
| Forward PE | 77.78 | 77.78 | 68.38 | 68.38 | 68.38 | |
| PS Ratio | 2.53 | 1.97 | 4.92 | 5.23 | 8.27 | 61.79 |
| PB Ratio | 2.11 | 1.39 | 2.50 | 2.67 | 0.80 | 3.48 |
| P/TBV Ratio | 2.11 | 1.39 | 2.50 | 2.67 | 0.80 | 3.48 |
| P/FCF Ratio | 6.67 | 4.57 | 2.77 | |||
| P/OCF Ratio | 6.64 | 4.52 | 2.76 | |||
| EV/Sales Ratio | 0.88 | 0.82 | 0.98 | 3.55 | 45.21 | |
| EV/EBITDA Ratio | 2.13 | 1.89 | ||||
| EV/EBIT Ratio | 2.15 | 1.91 | ||||
| EV/FCF Ratio | 2.32 | 1.91 | 0.55 | |||
| Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.02 | 0.03 | 0.03 |
| Debt / EBITDA Ratio | 0.10 | 0.09 | ||||
| Debt / FCF Ratio | 0.11 | 0.09 | 0.06 | |||
| Net Debt / Equity Ratio | -1.38 | -1.39 | -1.83 | -0.75 | -1.05 | -1.07 |
| Net Debt / EBITDA Ratio | -3.99 | -4.49 | 6.97 | 3.94 | 2.33 | 3.30 |
| Net Debt / FCF Ratio | -4.35 | -4.55 | -2.03 | 1.37 | 2.35 | 4.97 |
| Asset Turnover | 0.60 | 0.54 | 0.24 | 0.31 | 0.07 | 0.04 |
| Quick Ratio | 5.72 | 6.46 | 5.13 | 4.26 | 7.00 | 6.85 |
| Current Ratio | 5.72 | 6.56 | 5.26 | 4.36 | 7.23 | 7.21 |
| Return on Equity (ROE) | 50.64% | 44.84% | -23.62% | -26.19% | -36.55% | -30.20% |
| Return on Assets (ROA) | 15.46% | 14.42% | -7.88% | -7.54% | -19.54% | -16.21% |
| Return on Invested Capital (ROIC) | -80.07% | |||||
| Return on Capital Employed (ROCE) | 26.20% | 23.40% | -15.70% | -13.70% | -43.00% | -30.50% |
| Earnings Yield | 18.85% | 24.70% | -10.39% | -10.72% | -54.35% | -9.23% |
| FCF Yield | 15.00% | 21.89% | 36.12% | -20.62% | -55.79% | -6.20% |
| Buyback Yield / Dilution | -3.76% | -4.79% | -2.16% | -1.24% | -2.79% | -5.80% |